PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Botulinum toxin • Dermal fillers • Others • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Emergence of combination treatments • Growing demand from men for facial aesthetics • Increasing digital engagement PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Allergan • Anika Therapeutics • Contura • Ipsen • Merz Pharma • Nestlé PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global medical aesthetics market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global facial aesthetics market 2017-2022 ($ mn) Exhibit 09: Global facial aesthetics market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Botulinum toxin – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Botulinum toxin – Year-over-year growth 2018-2022 (%) Exhibit 22: Dermal fillers – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Dermal fillers – Year-over-year growth 2018-2022 (%) Exhibit 24: Others – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Others – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Global facial aesthetics market – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top three countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year over year growth 2018-2022 (%) Exhibit 35: Top three countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top three countries in APAC Exhibit 39: Market opportunity Exhibit 40: Growing percentage of elderly population 2010-2016 Exhibit 41: Average cost of dermal facial fillers Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Allergan: Overview Exhibit 48: Allergan– Business segments Exhibit 49: Allergan– Organizational developments Exhibit 50: Allergan – Geographic focus Exhibit 51: Allergan – Segment focus Exhibit 52: Allergan– Key offerings Exhibit 53: Anika Therapeutics: Overview Exhibit 54: Anika Therapeutics – Business segments Exhibit 55: Anika Therapeutics – Organizational developments Exhibit 56: Anika Therapeutics – Geographic focus Exhibit 57: Anika Therapeutics – Segment focus Exhibit 58: Anika Therapeutics – Key offerings Exhibit 59: Contura: Overview Exhibit 60: Contura – Business segments Exhibit 61: Contura – Organizational developments Exhibit 62: Contura – Geographic focus Exhibit 63: Contura – Segment focus Exhibit 64: Contura – Key offerings Exhibit 65: Ipsen: Overview Exhibit 66: Ipsen– Business segments Exhibit 67: Ipsen– Organizational developments Exhibit 68: Ipsen – Geographic focus Exhibit 69: Ipsen – Segment focus Exhibit 70: Ipsen – Key offerings Exhibit 71: Merz Pharma: Overview Exhibit 72: Merz Pharma– Business segments Exhibit 73: Merz Pharma – Organizational developments Exhibit 74: Merz Pharma – Geographic focus Exhibit 75: Merz Pharma – Segment focus Exhibit 76: Merz Pharma – Key offerings Exhibit 77: Nestlé: Overview Exhibit 78: Nestlé– Business segments Exhibit 79: Nestlé – Organizational developments Exhibit 80: Nestlé– Geographic focus Exhibit 81: Nestlé – Segment focus Exhibit 82: Nestlé– Key offerings

Allergan Anika Therapeutics Contura Ipsen Merz Pharma Nestlé